Endo, Itaru

Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)

Kiriyama, S., Kozaka, K., Takada, T., Strasberg, S. M., Pitt, H. A., Gabata, T., Hata, J., Liau, K., Miura, F., Horiguchi, A., et al. (2018) · Journal of Hepato-Biliary-Pancreatic Sciences

Gallbladder and Bile Duct DisordersSepsis Diagnosis and Treatment

Cited by 761

Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis

Gomi, H., Solomkin, J. S., Schlossberg, D., Okamoto, K., Takada, T., Strasberg, S. M., Ukai, T., Endo, I., Iwashita, Y., Hibi, T., et al. (2018) · Journal of Hepato-Biliary-Pancreatic Sciences

Gallbladder and Bile Duct DisordersAntibiotic Use and Resistance

Cited by 451

Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis

Mayumi, T., Okamoto, K., Takada, T., Strasberg, S. M., Solomkin, J. S., Schlossberg, D., Pitt, H. A., Yoshida, M., Gomi, H., Miura, F., et al. (2018) · Journal of Hepato-Biliary-Pancreatic Sciences

Gallbladder and Bile Duct DisordersClinical practice guidelines implementation

Cited by 311

Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

Sawada, Y., Yoshikawa, T., Ofuji, K., Yoshimura, M., Tsuchiya, N., Takahashi, M., Nobuoka, D., Gotohda, N., Takahashi, S., Kato, Y., et al. (2016) · OncoImmunology

Hepatocellular Carcinoma Treatment and PrognosisImmunotherapy and Immune Responses

Cited by 178

A Low Tumor Mutational Burden and PTEN Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal Tumors

Chida, K., Kawazoe, A., Kawazu, M., Suzuki, T., Nakamura, Y., Nakatsura, T., Kuwata, T., Ueno, T., Kuboki, Y., Kotani, D., et al. (2021) · Clinical Cancer Research

Cancer Immunotherapy and BiomarkersGenetic factors in colorectal cancer

Cited by 110

Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma

Tsuchiya, N., Yoshikawa, T., Fujinami, N., Saito, K., Mizuno, S., Sawada, Y., Endo, I., & Nakatsura, T. (2017) · OncoImmunology

Immunotherapy and Immune ResponsesHepatocellular Carcinoma Treatment and Prognosis

Cited by 67

Predictive Ability of Preoperative PT-INR and Postoperative MCP1 for Post-hepatectomy Liver Failure

ARISAKA, S., MATSUYAMA, R., GOTO, K., SUWA, Y., MORI, R., MORIOKA, D., TAGURI, M., & ENDO, I. (2020) · In Vivo

Hepatocellular Carcinoma Treatment and PrognosisOrgan Transplantation Techniques and Outcomes

Cited by 9